Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SNDQ vs GSK✓SelectedUSD · GSKSNDQ vs GSK performance historyLatest closeAs of+31.64%11/20
Stock and ETF performance explorer

SNDQ vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-49.5%
GSK return
-4.9%
Excess return
-44.5%
Maximum drawdown
-90.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+31.6%-0.1%+31.8%+31.9%
7D+75.8%-5.3%+81.2%+99.3%
30D+194.1%-3.7%+197.7%+222.3%
3M+220.0%-7.3%+227.2%+296.0%
6M-49.5%-4.2%-45.2%-34.5%
All-49.5%-4.9%-44.5%-34.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling